TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 42 filers reported holding TFF PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $962 | -25.5% | 2,747 | 0.0% | 0.00% | – |
| Q2 2023 | $1,291 | -31.2% | 2,747 | +0.3% | 0.00% | – |
| Q1 2023 | $1,876 | -33.1% | 2,738 | +2.5% | 0.00% | – |
| Q4 2022 | $2,805 | -97.6% | 2,672 | -90.8% | 0.00% | – |
| Q3 2022 | $119,000 | -3.3% | 29,094 | +34.3% | 0.00% | – |
| Q2 2022 | $123,000 | +778.6% | 21,669 | +904.1% | 0.00% | – |
| Q1 2022 | $14,000 | +180.0% | 2,158 | +232.0% | 0.00% | – |
| Q4 2021 | $5,000 | -83.3% | 650 | -83.5% | 0.00% | – |
| Q3 2021 | $30,000 | -21.1% | 3,950 | +0.9% | 0.00% | – |
| Q2 2021 | $38,000 | -5.0% | 3,913 | +31.5% | 0.00% | – |
| Q1 2021 | $40,000 | -82.9% | 2,976 | -81.8% | 0.00% | – |
| Q4 2020 | $234,000 | +444.2% | 16,317 | +587.9% | 0.00% | – |
| Q3 2020 | $43,000 | +95.5% | 2,372 | -39.6% | 0.00% | – |
| Q2 2020 | $22,000 | +46.7% | 3,930 | 0.0% | 0.00% | – |
| Q1 2020 | $15,000 | -64.3% | 3,930 | -50.3% | 0.00% | – |
| Q4 2019 | $42,000 | – | 7,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,058,823 | $19,556,000 | 9.92% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 220,666 | $4,076,000 | 4.24% |
| Mesirow Financial Investment Management, Inc. | 34,902 | $645,000 | 2.76% |
| Gagnon Advisors, LLC | 176,471 | $3,259,000 | 2.00% |
| Nantahala Capital Management | 2,032,988 | $37,549,000 | 1.15% |
| PRECEPT MANAGEMENT LLC | 235,294 | $4,346,000 | 1.07% |
| GAGNON SECURITIES LLC | 219,584 | $4,056,000 | 0.86% |
| Sepio Capital, LP | 84,560 | $1,562,000 | 0.17% |
| 683 Capital Management, LLC | 117,647 | $2,173,000 | 0.16% |
| SANDERS MORRIS HARRIS LLC | 21,326 | $340,000 | 0.09% |